Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v4-FR Version v3-EN
Language French English
Date Updated 2022-01-19 2022-01-19
Drug Identification Number 02245126 02245126
Brand name ADVAIR 125 ADVAIR 125
Common or Proper name fluticasone propionate and salmeterol pressurized inhalation, suspension fluticasone propionate and salmeterol pressurized inhalation, suspension
Company Name GLAXOSMITHKLINE INC GLAXOSMITHKLINE INC
Ingredients FLUTICASONE PROPIONATE SALMETEROL FLUTICASONE PROPIONATE SALMETEROL
Strength(s) 125MCG 25MCG 125MCG 25MCG
Dosage form(s) AEROSOL, METERED DOSE AEROSOL, METERED DOSE
Route of administration INHALATION INHALATION INHALATION INHALATION
Packaging size 1x120 1x120
ATC code R03AK R03AK
ATC description ADRENERGICS, INHALANTS ADRENERGICS, INHALANTS
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date
Actual start date 2021-12-09 2021-12-09
Estimated end date 2022-01-19 2022-01-19
Actual end date 2022-01-18 2022-01-18
Shortage status Resolved Resolved
Tier 3 Status No No
Company comments
Health Canada comments